SCHEMBL838044

SCHEMBL838044

C=C[C@H](C)[C@@](N)(C(N)=O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.54
CYP1A2 P05177 1/20 0.54
HTT P42858 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
CHRM3 P20309 2/20 0.40
KCNH2 Q12809 2/20 0.40
LMNA P02545 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
KDM4E B2RXH2 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
KCNN4 O15554 6/20 0.38
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2C19 P33261 1/20 0.37
KIF11 P52732 1/20 0.35
ALOX5 P09917 1/20 0.34
SLC22A2 O15244 1/20 0.34
SLC22A1 O15245 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4886581 1.00 CYP2D6 (0.54) CYP2D6CYP1A2HTTMAPTKMT2A
SCHEMBL838052 1.00 CYP2D6 (0.54) CYP2D6CYP1A2HTTMAPTKMT2A
SCHEMBL4989116 0.80 CYP2D6 (0.75) CYP2D6CYP1A2HTTMAPTKMT2A
SCHEMBL13246771 0.79 MAPT (0.47) MAPTTSHRALDH1A1CYP2C19CYP3A4
SCHEMBL13246769 0.75 MAPT (0.41) CYP2D6CYP1A2MAPTKMT2AKDM4E
SCHEMBL14042585 0.75 MAPT (0.41) CYP2D6CYP1A2MAPTKMT2AKDM4E
SCHEMBL4896201 0.73 CYP2D6 (0.40) CYP2D6CYP1A2HTTMAPTKMT2A
SCHEMBL838388 0.73 CYP2D6 (0.40) CYP2D6CYP1A2HTTMAPTKMT2A
SCHEMBL10048583 0.73 CYP2D6 (0.40) CYP2D6CYP1A2HTTMAPTKMT2A
SCHEMBL17513527 0.73 CYP1A2 (0.53) CYP2D6CYP1A2HTTMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143451-B2 Reacting a ketone with an allyl boron compound anc ammonia or ammonium salt; synthons KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2012-03-27 US disclosed
US-20080139847-A1 METHODS OF PREPARING TERTIARY CARBINAMINE COMPOUNDS KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2008-06-12 US disclosed
US-20080139847-A1 METHODS OF PREPARING TERTIARY CARBINAMINE COMPOUNDS KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139847-A1 METHODS OF PREPARING TERTIARY CARBINAMINE COMPOUNDS INMT, CROCC, GNMT CYP2D6 2234/4885CYP1A2 528/4885HTT 1319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.